Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2018

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
BEHAVIORAL

Intensive treatment

Subjects will be followed by the dietician in combination with his/her endocrinologist. Diet, physical activity, smoking cessation and drug prescriptions will be used to treat subjects.

OTHER

Normal follow-up

Subject will continue to be followed by their endocrinologist and general practitioner as they already do.

Trial Locations (1)

J1H 5N4

Centre de recherche clinique Étienne-Le Bel du CHUS, Sherbrooke

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Université de Sherbrooke

OTHER